Company Profile
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Latest News
Kelun-Biotech Receives a Clinical Trial Notice for Its First Dual-payload ADC SKB565
UK TV comedy star and naturalist Bill Oddie dies at 85
German creator of 'Body Worlds' anatomy exhibits dead at 81
Net Asset Value(s)
Prediction Markets Are Booming, Crypto Markets Are Not. Here's What That Means for Crypto Investors
| Sector | Healthcare |
| Industry | Medical Distribution |
| Website | https://www.ebosgroup.com |
| Audit Risk | 3 |
| Board Risk | 8 |
| Overall Risk | 6 |
| Market Cap | 4.48B |
| Trailing P/E | 17.47 |
| Forward P/E | 14.42 |
| Dividend Rate | 1.19 |
| Dividend Yield | 5.43% |
| Trailing Annual Div. Rate | 1.83 |
| Trailing Annual Div. Yield | 8.34% |
| Trailing EPS | 1.25 |
| Forward EPS | 1.51 |
| Book Value | 16.19 |
| Price-to-Book | 1.35 |
| Enterprise-to-Revenue | 0.32 |
| Enterprise-to-EBITDA | 14.47 |
| Ex-Dividend Date | 03/05/2026 |
| Earnings Date | 08/19/2026 |
| Earnings Call Date | 08/25/2026 |